And the potential anti-muscle atrophy effects and mechanisms of daidzein demonstrated in our study might provide insights into support the therapeutic potential by targeting AMPK/FOXO3a axis in the management of statin-induced muscle disorders. The gene discussed is FOXO3; the disease is muscular disease.